| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 92004 |
Ophthalmological services: medical examination and evaluation, comprehensive, new patient |
7,441 |
6,546 |
$322K |
| 99310 |
Prolong nursin fac eval 15m |
7,979 |
7,504 |
$258K |
| V2203 |
Spherocylinder, bifocal, plano to plus or minus 4.00d sphere, .12 to 2.00d cylinder, per lens |
2,039 |
1,055 |
$163K |
| V2744 |
Tint, photochromatic, per lens |
2,089 |
787 |
$151K |
| V2020 |
Frames, purchases |
2,688 |
1,435 |
$142K |
| 99308 |
Subsequent nursing facility care, per day, straightforward |
6,391 |
5,928 |
$102K |
| V2781 |
Progressive lens, per lens |
656 |
305 |
$91K |
| 92015 |
Determination of refractive state |
16,808 |
15,337 |
$84K |
| 92014 |
Ophthalmological services: medical examination and evaluation, comprehensive, established patient |
3,459 |
3,233 |
$82K |
| 99309 |
Subsequent nursing facility care, per day, low to moderate complexity |
3,779 |
3,580 |
$72K |
| 92012 |
Ophthalmological services: medical examination and evaluation, intermediate, established patient |
1,165 |
1,020 |
$23K |
| V2103 |
Spherocylinder, single vision, plano to plus or minus 4.00d sphere, .12 to 2.00d cylinder, per lens |
299 |
132 |
$19K |
| S0620 |
Routine ophthalmological examination including refraction; new patient |
246 |
246 |
$11K |
| 99337 |
|
84 |
79 |
$8K |
| 92341 |
|
322 |
317 |
$5K |
| 92250 |
|
841 |
801 |
$5K |
| V2783 |
Lens, index greater than or equal to 1.66 plastic or greater than or equal to 1.80 glass, excludes polycarbonate, per lens |
24 |
13 |
$3K |
| V2784 |
Lens, polycarbonate or equal, any index, per lens |
254 |
112 |
$2K |
| 92340 |
Fitting of spectacles, except for aphakia; monofocal |
67 |
67 |
$1K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
21 |
18 |
$289.23 |
| 92285 |
|
80 |
76 |
$227.87 |
| 2022F |
|
678 |
572 |
$0.04 |
| 4177F |
|
2,017 |
1,745 |
$0.00 |
| 3284F |
|
1,483 |
1,378 |
$0.00 |
| G9974 |
Dilated macular exam performed, including documentation of the presence or absence of macular thickening or geographic atrophy or hemorrhage and the level of macular degeneration severity |
1,744 |
1,483 |
$0.00 |
| 2027F |
|
806 |
780 |
$0.00 |